Company Filing History:
Years Active: 2002
Title: Michael Morlock: Innovator in Pharmaceutical Technology
Introduction
Michael Morlock is a notable inventor based in Viernheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy and stability of pharmaceutical formulations.
Latest Patents
Morlock holds a patent for "Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof." This invention pertains to parenteral pharmaceutical forms that utilize microparticles containing polypeptides. The microparticles are designed with a biodegradable polymer, specifically an ABA triblock copolymer, which includes a copolymer of lactic and glycolic acid and a polyethylene glycol chain. The formulation allows for the continuous release of polypeptides over an extended period, even in small quantities that are prone to aggregation.
Career Highlights
Michael Morlock is currently associated with Roche Diagnostics GmbH, a leading company in the field of diagnostics and pharmaceuticals. His role involves research and development, where he applies his expertise to create advanced pharmaceutical solutions. His innovative approach has led to the successful development of new drug delivery systems that improve patient outcomes.
Collaborations
Throughout his career, Morlock has collaborated with esteemed colleagues such as Hans Koll and Gerhard Winter. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical technology.
Conclusion
Michael Morlock's contributions to the pharmaceutical industry exemplify the importance of innovation in drug delivery systems. His patented work on microparticle formulations showcases his commitment to improving healthcare through scientific advancements.